(Q32060369)

English

Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 July 2017

Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study (English)

1 reference

Europe PubMed Central

6 July 2017

multicenter clinical trial

0 references

hydrochlorothiazide

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

F Freytag

1

1 reference

Europe PubMed Central

6 July 2017

A Schelling

2

1 reference

Europe PubMed Central

6 July 2017

T Meinicke

3

1 reference

Europe PubMed Central

6 July 2017

G Deichsel

4

1 reference

Europe PubMed Central

6 July 2017

Telmisartan Hypertension Experience in a Randomized European Study Versus Atenolol Study Group

5

1 reference

Europe PubMed Central

6 July 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

6 July 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

6 July 2017

23

1 reference

Europe PubMed Central

6 July 2017

1

1 reference

Europe PubMed Central

6 July 2017

108-123

1 reference

Europe PubMed Central

6 July 2017

Angiotensin-II-receptors: new targets for antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry. American Society of Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving outcomes in congestive heart failure: Val-HeFT. Valsartan in Heart Failure Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancing cardiac protection after myocardial infarction: rationale for newer clinical trials of angiotensin receptor blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure and isolated systolic hypertension and the risk of coronary heart disease and mortality in elderly men (the Zutphen Elderly Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of systolic and diastolic blood pressure on stroke risk: a prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Is diastolic hypertension an independent risk factor for stroke in the presence of normal systolic blood pressure in the middle-aged and elderly?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The place of combination therapy in the treatment of hypertension in 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A risk-benefit assessment of losartan potassium in the treatment of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980034-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(01)80034-5

1 reference

Europe PubMed Central

6 July 2017

1 reference

Europe PubMed Central

6 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32060369&oldid=1628109971"